A 45-year old female patient is prescribed a chemotherapy regime with moderate emetogenic potential. She has just received her first dose of CMF; Cyclophosphamide, Methotrexate, 5- Flourouracil as neoadjuvant chemotherapy prior to a mastectomy. You are asked to recommend an antiemetic for management of her acute symptoms.